John Yip to succeed Shirlee Sharkey at SE Health
January 26, 2022
MARKHAM, Ont. – Following a rigorous selection process, SE Health is announcing that John Yip (pictured) has been appointed to succeed Shirlee Sharkey as the president and CEO, effective May 3, 2022.
John brings over 20 years of leadership experience in the health sector and is currently the president and CEO of Kensington Health, a diversified not-for-profit community-based health services provider. John’s ability to deliver impactful care to communities while remaining mission-focused with an entrepreneurial spirit is incredibly aligned with our strategic imperatives at SE Health.
Read More
HAMILTON, Ont. – Hamilton Health Sciences Centre has announced the appointment of Dr. Marc Jeschke (pictured) as vice president of research at HHS, commencing on June 1, 2022.
Dr. Jeschke brings world-renowned expertise to the organization in the field of translational research through which basic scientific and medical research are brought into day-to-day clinical applications that directly benefit patient care. He brings a superb track record as a research leader with a proven ability to attract funding and grants from various national programs and agencies to advance innovative medical care in burns.
MONTREAL – Dr. Lawrence Rosenberg (pictured), president and CEO of CIUSSS West-Central Montreal, has been named by Industry Era magazine as one of the 10 most inspiring CEOs of 2021.
According to an article in the U.S.-based magazine, Dr. Rosenberg was recognized for his strides in improving healthcare and social services through the use of artificial intelligence and the development of OROT, the CIUSSS’s connected health innovation hub.
OTTAWA – Mary Simon, Governor General of Canada, announced 135 appointments to the Order of Canada at the end of December. The new appointees include several persons who have made outstanding contributions to healthcare and health technology.
WINDSOR, Ont. – On November 1st, the Hôtel-Dieu Grace Healthcare (HDGH) board of directors shared the retirement notice of the president and CEO, Janice Kaffer, as well as the announcement of Bill Marra (pictured) accepting the role of president and CEO. While this transition was anticipated no later than March 31, 2022 and April 1, 2022 respectively, the HDGH board of directors have made the decision to advance the planned transition to January 1, 2022.
TORONTO – The OntarioMD board of directors is pleased to announce that Robert Fox (pictured) has been appointed chief executive officer (CEO), effective January 10, 2022. He has 25 years of experience leading large teams, defining health policy and enhancing the healthcare system.
Robert believes that the adoption of healthcare technology is a critical success factor for the optimization and sustainability of Canada’s healthcare system.
TORONTO – Dr. Mary Gospodarowicz (pictured), former medical director at the Princess Margaret Cancer Centre, is the recipient of the 2021 UHN Global Impact Award.
Dr. Gospodarowicz, who held the leadership post at the cancer centre for more than 15 years until 2020, was cited for the award by the selection committee because of “her academic and clinical accomplishments resulting in improved cancer outcomes for patients around the world.”
LONDON, Ont. – The Board of Directors of London Health Sciences Centre (LHSC) has announced the appointment of Dr. Jackie Schleifer Taylor (pictured) as president and CEO of the organization. This follows an extensive and rigorous executive search.
“Dr. Schleifer Taylor brings a wealth of hospital and health system experience and a proven track record of leadership to this position. She is an inspiring and transformative leader with a vision both for LHSC and Ontario’s health system,” said Phyllis Retty, chair of the Board of Directors.
MARKHAM, Ont. – After 30 years of breakthrough leadership, Shirlee Sharkey (pictured) has announced her intention to step down as the CEO of SE Health in spring 2022.
Shirlee has spent the last three decades shaping SE Health into a thriving not-for-profit social enterprise that creates shared value through its business of caring, social impact and strategic investments.
TORONTO – Medtech Canada’s board of directors announces that Nicole DeKort (pictured) has been named as the association’s next president and CEO, as of November 1, 2021.
“On behalf of Medtech Canada’s board of directors, we are very pleased to have an individual of the calibre of Nicole DeKort as president and CEO of our association,” says Dave O’Neil, Medtech Canada board chair and VP & managing director of Smith & Nephew Canada.